...
首页> 外文期刊>International journal of clinical oncology >Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
【24h】

Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis

机译:基于综合生物信息学分析,鉴定蛇纹石1,甲基和acta1作为头部鳞状细胞癌的生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Background Head and neck squamous cell carcinoma (HNSCC) is the six leading cancer by incidence worldwide. The 5-year survival rate of HNSCC patients remains less than 65% due to lack of symptoms in the early stage. Hence, biomarkers which can improve detection of HNSCC should improve clinical outcome. Methods Gene expression profiles (GSE6631, GSE58911) and the Cancer Genome Atlas (TCGA) HNSCC data were used for integrated bioinformatics analysis; the differentially expressed genes (DEGs) were then subjected to functional and pathway enrichment analysis, protein-protein interaction (PPI) network construction. Subsequently, module analysis of the PPI network was performed and overall survival (OS) analysis of hub genes in subnetwork was studied. Finally, immunohistochemistry was used to verify the selected markers. Results A total of 52 up-regulated and 80 down-regulated DEGs were identified, which were mainly associated with ECM-receptor interaction and focal adhesion signaling pathways. Importantly, a set of prognostic signatures including SERPINE1, PLAU and ACTA1 were screened from DEGs, which could predict OS in HNSCC patients from TCGA cohort. Experiment of clinical samples further successfully validated that these three signature genes were aberrantly expressed in the oral epithelial dysplasia and HNSCC, and correlated with aggressiveness of HNSCC patients. Conclusions SERPINE1, PLAU and ACTA1 played important roles in regulating the initiation and progression of HNSCC, and could be identified as key biomarkers for precise diagnosis and prognosis of HNSCC, which will provide potential targets for clinical therapies.
机译:背景头和颈部鳞状细胞癌(HNSCC)是全世界入学率的六种主要癌症。由于早期缺乏症状,HNSCC患者的5年的活力率仍然不到65%。因此,可以改善HNSCC检测的生物标志物应该改善临床结果。方法基因表达谱(GSE6631,GSE58911)和癌症基因组Atlas(TCGA)HNSCC数据用于集成生物信息学分析;然后对差异表达的基因(DEGS)进行功能性和途径富集分析,蛋白质 - 蛋白质相互作用(PPI)网络施工。随后,研究了PPI网络的模块分析,并研究了子网中的集线基因的总存活(OS)分析。最后,使用免疫组织化学来验证所选标志物。结果鉴定了总共52个上调和80个下调的次数,其主要与ECM受体相互作用和局灶性粘附信号通路相关。重要的是,从DEGS筛选一组预后签名,包括Serpine1,Plau和Acta1,其可以预测来自TCGA队列的HNSCC患者的OS。临床样品的实验进一步证明了这三种签名基因在口腔上皮发育不良和HNSCC中表达,并与HNSCC患者的攻击性相关。结论Serpine1,Plau和Acta1在调节HNSCC的启动和进展方面发挥了重要作用,可被确定为HNSCC精确诊断和预后的关键生物标志物,这将为临床疗法提供潜在的靶标。

著录项

  • 来源
  • 作者单位

    Shandong Univ Dept Oral &

    Maxillofacial Surg Prov Hosp Jinan 250021 Shandong Peoples R China;

    Shandong Univ Dept Oral &

    Maxillofacial Surg Prov Hosp Jinan 250021 Shandong Peoples R China;

    Shandong Univ Dept Oral &

    Maxillofacial Surg Prov Hosp Jinan 250021 Shandong Peoples R China;

    Sun Yat Sen Univ Guangdong Prov Key Lab Stomatol Dept Oral &

    Maxillofacial Surg Guanghua Sch;

    Shandong Univ Dept Oral &

    Maxillofacial Surg Prov Hosp Jinan 250021 Shandong Peoples R China;

    Shandong Univ Dept Oral &

    Maxillofacial Surg Prov Hosp Jinan 250021 Shandong Peoples R China;

    Shandong Univ Stomatol Hosp Shangdong Prov Key Lab Oral Tissue Regenerat Jinan Shandong;

    Shandong Univ Dept Oral &

    Maxillofacial Surg Prov Hosp Jinan 250021 Shandong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    HNSCC; Biomarkers; Differentially expressed genes; Integrated bioinformatics analysis;

    机译:HNSCC;生物标志物;差异表达基因;综合生物信息学分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号